NovoCare Pharmacy Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.9/10
Best for: an oral route if you will not self-inject
NovoCare Pharmacy scores highest on price and lowest on ease of signing up. It charges from $149 a month; its brand-name semaglutide, at $349, is 73% below the $1,299 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
NovoCare Pharmacy is Novo Nordisk's own direct-to-patient pharmacy for Wegovy and, now, Ozempic. Self-pay Wegovy pills run $149 to $299 a month by dose, and new patients pay $199 for the first two months of a Wegovy or Ozempic pen before the $349 standard price; Wegovy HD is $399 and Ozempic 2 mg $499. It fills prescriptions but does not write them; it links to telehealth prescribers.
Is NovoCare Pharmacy legit?
Yes. NovoCare Pharmacy is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.9/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a NovoCare Pharmacy promo or coupon code?
NovoCare Pharmacy has no code to type in. The current offer: Wegovy new-patient self-pay offer: $199/month for the first 2 months (pill), then standard $349/month pen pricing; official Novo Nordisk NovoCare site. It applies at checkout on its own. Coupon sites advertising a "NovoCare Pharmacy promo code" are not a source we can vouch for.
See how NovoCare Pharmacy compares on our rankings of the best semaglutide providers.
Vetted alternatives to NovoCare Pharmacy
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Found
Best for: people who want clinician visits billed to commercial insurance, with compounded medication in the plan price
Editorial score · methodology
NovoCare Pharmacy at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Wegovy, Ozempic
- Starting price
- $149/mo (Self-pay; one month is one bottle of 30 tablets)
- Pricing model
- Rises with the dose: higher doses cost more
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How NovoCare Pharmacy scores
Six columns, each one computed from something NovoCare Pharmacy has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
10.0/10$349/month is 73% below the $1,299 median for brand-name semaglutide across the sellers we compare.
Effectiveness25%
9.0/10Dispenses semaglutide, including the FDA-approved product. Anchored to STEP 1 (semaglutide, -14.9%).
User Experience15%
5.0/10Where this seller first shows a price is not known, so sign-up is held at the midpoint.
Trust & Safety15%
6.0/10No pharmacy is named for its prescriptions. There is no confirmed price before the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on NovoCare Pharmacy
Last checked October 2026- Checked the listed price across 10 dose or plan tiers
- Checked state coverage: all 50
- Checked FDA warning letters for NovoCare Pharmacy
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
Medications NovoCare Pharmacy lists
NovoCare Pharmacy lists Wegovy and Ozempic. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Self-pay; one month is one bottle of 30 tablets
Self-pay; one month is one bottle of 30 tablets
Self-pay; one month is one bottle of 30 tablets
$199/mo intro = first 2 monthly fills (0.25/0.5 mg) for patients new to the offer/pharmacy, through 12/31/2026; then $349/mo standard
With commercial insurance, as little as $25 a month for up to 3 months; maximum savings $100 a month. Government beneficiaries excluded.
For eligible adult Medicare patients prescribed Wegovy for weight loss, starting July 1.
$199 a month for the first 2 fills of 0.25/0.5 mg for patients new to the offer or pharmacy, through December 31, 2026; then $349.
Self-pay price varies by dose; one month is one bottle of 30 tablets.
Check the price yourself before you pay
Every figure here comes from NovoCare Pharmacy's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $349 a month, 73% below the $1,299 median for brand-name semaglutide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to NovoCare Pharmacy
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
What NovoCare Pharmacy charges
NovoCare Pharmacy lists $149/month.
- Wegovy (1.5 mg): $149/month
- Wegovy (4 mg): $199/month
- Wegovy (9 mg or 25 mg): $299/month
- Wegovy pen (0.25-2.4 mg): $199/month for the first two fills, then $349/month
- Wegovy pen (7.2 mg): $399/month
- Wegovy with insurance (commercial): $25/month
For brand-name semaglutide, the median across the sellers we compare is $1,299/month, so NovoCare Pharmacy's $349 is genuinely below the middle, not just advertised that way.
Found, at about $149/month + membership, is the closest like-for-like alternative we review.
What NovoCare Pharmacy dispenses
NovoCare Pharmacy prescribes semaglutide (approved as Wegovy and Ozempic). That is one of the most heavily studied molecules in this class. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the pen has been reviewed. Brand names vs molecules sorts out which pen holds which drug. The Wegovy pill is priced by dose; what it costs each way you can pay compares the routes.
Safety and disclosure
NovoCare Pharmacy tells you that it treats patients in all 50 states. We found no FDA warning letters issued to NovoCare Pharmacy. The FDA's warning signs for online medicine sellers are a quick check to run on any seller before you pay. How we weigh oversight, disclosure and price is set out in our scoring methodology.
It fits if
- the lowest standing monthly cost is what you are solving for
- you need access wherever you live
- you want to try routing the cost through your insurance, where coverage is decided in three steps
Our read
NovoCare Pharmacy competes on price without an obvious sacrifice elsewhere: $349/month for brand-name semaglutide, no FDA warning letters, and wide state coverage.
The Bottom Line
NovoCare Pharmacy scores highest on price and lowest on ease of signing up. It charges from $149 a month; its brand-name semaglutide, at $349, is 73% below the $1,299 median among the sellers we compare.
Before you pay NovoCare Pharmacy
Starting at $149 a month. Check today's price, then start the intake.
Where NovoCare Pharmacy is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider WellMedRx (from $49/mo).
- If you want a human checking in, not just a prescription, consider Found.
If none of these fits, our guide to alternatives to NovoCare Pharmacy sets more sellers in the same category beside NovoCare Pharmacy on price, states and what the price includes.
Frequently Asked Questions
How to check NovoCare Pharmacy yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
Every seller that ships to your state, side by side: Delaware, Hawaii, Kentucky, Maine, Mississippi, Montana, South Dakota, Wisconsin and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this NovoCare Pharmacy review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See NovoCare Pharmacy's current pricing
Plans start at $149 a month. Whether you qualify is a clinician's decision, made after your intake.